KITE-363

· Kite, A Gilead Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KITE-363, covering 2026-04-06 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma [Phase 1, Phase 2]